As the United States stock market navigates a period of volatility amid President Trump's anticipated announcement on new tariffs, major indices like the Dow Jones and S&P 500 have shown resilience with recent gains despite earlier declines. In such an unpredictable environment, identifying stocks that may be trading below their estimated value can offer investors potential opportunities for growth while balancing the risks presented by ongoing economic uncertainties.
Top 10 Undervalued Stocks Based On Cash Flows In The United States
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| WesBanco (NasdaqGS:WSBC) | $30.65 | $59.93 | 48.9% |
| Semrush Holdings (NYSE:SEMR) | $9.56 | $19.03 | 49.8% |
| Berkshire Hills Bancorp (NYSE:BHLB) | $26.09 | $51.48 | 49.3% |
| Valley National Bancorp (NasdaqGS:VLY) | $8.89 | $17.28 | 48.6% |
| ACNB (NasdaqCM:ACNB) | $41.36 | $82.27 | 49.7% |
| AGNC Investment (NasdaqGS:AGNC) | $9.49 | $18.57 | 48.9% |
| Smurfit Westrock (NYSE:SW) | $45.62 | $89.95 | 49.3% |
| CI&T (NYSE:CINT) | $5.99 | $11.73 | 49% |
| Advanced Micro Devices (NasdaqGS:AMD) | $102.78 | $204.24 | 49.7% |
| Haemonetics (NYSE:HAE) | $63.02 | $124.71 | 49.5% |
We'll examine a selection from our screener results.
Lincoln Educational Services (NasdaqGS:LINC)
Overview: Lincoln Educational Services Corporation offers career-oriented postsecondary education services to high school graduates and working adults in the United States, with a market cap of approximately $501.38 million.
Operations: The company generates revenue through its Transitional segment, which accounts for $7.10 million, and Campus Operations, contributing $432.97 million.
Estimated Discount To Fair Value: 33.3%
Lincoln Educational Services is trading at US$16.16, significantly below its estimated fair value of US$24.23, suggesting it may be undervalued based on cash flows. Recent amendments to its credit agreement with Fifth Third Bank enhance financial flexibility, supporting growth initiatives. Despite a lower net profit margin compared to last year, earnings are expected to grow by 41% annually over the next three years, outpacing the broader US market's growth rate of 13.8%.
- According our earnings growth report, there's an indication that Lincoln Educational Services might be ready to expand.
- Click to explore a detailed breakdown of our findings in Lincoln Educational Services' balance sheet health report.
MetroCity Bankshares (NasdaqGS:MCBS)
Overview: MetroCity Bankshares, Inc. is a bank holding company for Metro City Bank, offering various banking products and services in the United States, with a market cap of approximately $700.35 million.
Operations: MetroCity Bankshares generates its revenue primarily through its Community Banking segment, which accounts for $140.69 million.
Estimated Discount To Fair Value: 48.2%
MetroCity Bankshares is trading at US$27.62, significantly below its estimated fair value of US$53.34, indicating potential undervaluation based on cash flows. With earnings forecasted to grow by 21.39% annually and revenue expected to increase by 21.7% per year, the company demonstrates robust growth prospects compared to the broader US market. Recent financial results show net interest income rising to US$30.06 million and net income increasing to US$16.24 million year-over-year, underscoring strong performance momentum.
- The growth report we've compiled suggests that MetroCity Bankshares' future prospects could be on the up.
- Get an in-depth perspective on MetroCity Bankshares' balance sheet by reading our health report here.
Privia Health Group (NasdaqGS:PRVA)
Overview: Privia Health Group, Inc. is a national physician-enablement company operating in the United States with a market cap of approximately $2.71 billion.
Operations: The company generates revenue of $1.74 billion from its Healthcare Facilities & Services segment.
Estimated Discount To Fair Value: 42.9%
Privia Health Group's current trading price of US$22.88 is substantially below its estimated fair value of US$40.04, highlighting potential undervaluation based on cash flows. The company forecasts significant earnings growth at 30.4% annually, surpassing the broader market's expectations. Recent financial results show Q4 sales increased to US$460.9 million with net income rising to US$4.4 million year-over-year, although profit margins have slightly decreased from the previous year.
- Our comprehensive growth report raises the possibility that Privia Health Group is poised for substantial financial growth.
- Unlock comprehensive insights into our analysis of Privia Health Group stock in this financial health report.
Turning Ideas Into Actions
- Dive into all 192 of the Undervalued US Stocks Based On Cash Flows we have identified here.
- Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
- Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.
Ready To Venture Into Other Investment Styles?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Privia Health Group might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com